Enhance immune response to DNA vaccine based on a novel multicomponent supramolecular assembly

Biomaterials

Volumn 28, Issue 31, 2007, Pages 4684-4692

  Zhou, Xianfeng ^a   Liu, Bin ^a   Yu, Xianghui ^a   Zha, Xiao ^a,b   Zhang, Xizhen ^a   Wang, Xueyun ^a   Chen, Yu ^a   Chen, Yan ^a   Chen, Yue ^a   Shan, Yaming ^a   Jin, Yinghua ^a   Wu, Yongge ^a   Liu, Junqiu ^a   Kong, Wei ^a   Shen, Jiacong ^a  

^a JILIN UNIVERSITY   (China)

^b SICHUAN CANCER HOSPITAL   (China)

Author keywords

Artificial virus; DNA vaccine; Immunogenicity; Mannose bearing Chitosan oligomers microspheres; Supramolecular assembly

Indexed keywords

DISEASES; DNA; MICROSPHERES; OLIGOMERS; VACCINES;

DNA VACCINE; MANNOSE-BEARING CHITOSAN OLIGOMERS MICROSPHERES; SUPRAMOLECULAR ASSEMBLY;

IMMUNOLOGY;

CHITOSAN; DNA VACCINE; MANNOSE; MICROSPHERE; OLIGOMER; POLYETHYLENEIMINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DNA IMMUNIZATION; DRUG FORMULATION; FEMALE; GENE TARGETING; IMMUNE RESPONSE; IMMUNOGENICITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROPHYLAXIS; SUPRAMOLECULAR CHEMISTRY;

ANIMALS; BIOCOMPATIBLE MATERIALS; CERCOPITHECUS AETHIOPS; CHITOSAN; COS CELLS; DRUG CARRIERS; FEMALE; IMMUNITY, NATURAL; MACROMOLECULAR SUBSTANCES; MANNOSE; MATERIALS TESTING; MICE; MICE, INBRED BALB C; VACCINES, DNA;

MUS;

EID: 34547876897     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2007.07.002     Document Type: Article

References (37)

1. Donnelly J.J., Ulmer J.B., Shiver J.W., and Liu M.A. DNA vaccine. Ann Rev Immunol 15 (1997) 617-648
2. Letvin N.L., Montefiori D.C., Yasutomi Y., Perry H.C., Davies M.E., Lekutis C., et al. Potent, protective anti-HIV immune responses generated by bimodal HIV envelope DNA plus protein vaccination. Proc Natl Acad Sci USA 94 (1997) 9378-9383
3. Calatota S., Bratt G., Nordlund S., Hinkula J., Leandersson A.C., Sandstrom E., et al. Cellular cytotoxic responses induced by DNA vaccination in HIV-1-infected patients. Lancet 351 (1998) 1320-1325
4. Wang R., Doolan D.L., Le T.P., Hedstrom R.C., Coonan K.M., Charoenvit Y., et al. Induction of antigen-specific cytotoxic T lymphocytes in humans by a malaria DNA vaccine. Science 282 (1998) 476-480
5. Boutorine A.S., and Kostina E.V. Reversible covalent attachment of cholesterol to oligodeoxy-ribonucleotides for studies of the mechanisms of their penetration into eukaryotic cells. Biochimie 75 (1993) 35-41
6. Barry M.E., Pinto-Gonzalez D., Orson F.M., McKenzie G.J., Petry G.R., and Barry M.A. Role of endogenous endonucleases and tissue site in transfection and CpG-mediated immune activation after naked DNA injection. Hum Gene Ther 10 (1999) 2461-2480
7. Hasan U.A., Abai A.M., Harper D.R., Wren B.W., and Morrow W.J. Nucleic acid immunization: concepts and techniques associated with third generation vaccines. J Immunol Methods 229 (1999) 1-22
8. Pouton C.W., and Seymour L.W. Key issues in non-viral gene delivery. Adv Drug Deliv Rev 46 (2001) 187-203
9. Singh M., Briones M., Ott G., and O'Hagan D. Cationic microparticles: a potent delivery system for DNA vaccines. Proc Natl Acad Sci USA 97 (2000) 811-816
10. Illum L., Jabbal-Gill I., Hinchcliffe M., Ficsher A.N., and Davis S.S. Chitosan as a novel nasal delivery system for vaccines. Adv Drug Deliv Rev 51 (2001) 81-96
11. Shiver J.W., Fu T.M., Chen L., Casimiro D.R., Davies M.E., Evans R.K., et al. Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity. Nature 415 (2002) 331-335
12. Felgner J.H., Kumar R., Sridhar C.N., Wheeler C.J., Tsai Y.J., Border R., et al. Enhanced gene delivery and mechanism studies with a novel series of cationic lipid formulations. J Biol Chem 269 (1994) 2550-2561
13. Gregoriadis G., McCormack B., Obrenovic M., Saffie R., Zadi B., and Perrie Y. Vaccine entrapment in liposomes. Methods 19 (1999) 156-162
14. Somia N., and Verma I.M. Gene therapy: trial and tribulations. Nat Rev Genet 1 (2000) 91-99
15. Ogris M., and Wagner E. Targeting tumors with non-viral gene delivery systems. Drug Discov Today 7 (2002) 479-485
16. Hood J.D., Bednarski M., Frausto R., Guccione S., Reisfeld R.A., Xiang R., et al. Tumor regression by targeted gene delivery to the neovasculature. Science 296 (2002) 2404-2407
17. Corr M., Lee D.J., Carson D.A., and Tighe H. Gene vaccination with naked plasmid DNA: mechanism of CTL priming. J Exp Med 184 (1996) 1555-1560
18. Doe B., Selby M., Barnett S., Baenziger J., and Walker C.M. Induction of cytotoxic T lymphocytes by intramuscular immunization with plasmid DNA is facilitated by bone marrow-derived cells. Proc Natl Acad Sci USA 93 (1996) 8578-8583
19. Mansur Y., and Laurance D.H. Some chemical and analytical aspects of polysaccharide modifications. 3. Formation of branch-chain, soluble chitosan derivatives. Macromolecules 17 (1984) 272-281
20. Peniston QP. 1975; USP, 3922260.
21. Park J.H., Cho Y.W., Chung H., Kwon I.C., and Jeong S.Y. Synthesis and characterization of sugar-bearing chitosan derivatives: aqueous solubility and biodegradability. Biomacromolecules 4 (2003) 1087-1091
22. Aral C., and Akbuga J. Preparation and in vitro transfection efficiency of chitosan microspheres containing plasmid DNA: poly(l-lysine) complexes. J Pharm Pharm Sci 6 (2003) 321-326
23. Garg S., Oran A., Wajchman J., Sasaki S., Maris C.H., Kapp J.A., et al. Genetic tagging shows increased frequency and longevity of antigen-presenting, skin-derived dendritic cells in vivo. Nat Immunol 4 (2003) 907-912
24. Deml L. Purification and characterization of hepatitis B virus surface antigen particles produced in Drosophila Schneider-2 cells. J Virol Methods 79 (1999) 205-217
25. Rico M.A., Quiroga J.A., Subira D., Castanon S., Esteban J.M., Pardo M., et al. Hepatitis B virus-specific T-cell proliferation and cytokine secretion in chronic hepatitis B e antibody-positive patients treated with ribavirin and interferon alpha. Hepatology 33 (2000) 295-300
26. Seder R.A., and Hill A.V. Vaccines against intracellular infections requiring cellular immunity. Nature 406 (2000) 793-798
27. Nakai T., Kanamori T., Sando S., and Aoyama T. Remarkably size-regulated cell invasion by artificial viruses. Saccharide-dependent self-aggregation of glycoviruses and its consequences in glycoviral gene delivery. J Am Chem Soc 125 (2003) 8465-8475
28. Zuber G., Zammut-Italiano L., Dauty E., and Behr J.P. Targeted gene delivery to cancer cells: directed assembly of nanometric DNA particles coated with folic acid. Angew Chem Int Ed Engl 42 (2003) 2666-2669
29. Luo D., and Saltzman W.M. Synthetic DNA delivery systems. Nat Biotechnol 18 (2000) 33-37
30. Lee M.K., Chun S.K., Kim J.K., Choi S.H., Kim A., Ounqbho K., et al. The use of chitosan as a condensing agent to enhance emulsion-mediated gene transfer. Biomaterials 26 (2005) 2147-2156
31. Onishi H., and Machida Y. Biodegradation and distribution of water-soluble chitosan in mice. Biomaterials 20 (1999) 175-182
32. Koping-Hoggard M., Tubulekas I., Guan H., Edwards K., Nilsson M., Varum K.M., et al. Chitosan as a nonviral gene delivery system. Structure- property relationships and characteristics compared with polyethylenimine in vitro and after lung administration in vivo. Gene Ther 8 (2001) 1108-1121
33. Lavertu M., Methot S., Tran-Khanh N., and Buschmann M.D. High efficiency gene transfer using chitosan/DNA nanoparticles with specific combinations of molecular weight and degree of deacetylation. Biomaterials 27 (2006) 4815-4824
34. Plank C., Mechtler K., Szoka Jr. F.C., and Wagner E. Activation of the complement system by synthetic DNA complexes: a potential barrier for intravenous gene delivery. Hum Gene Ther 7 (1996) 1437-1446
35. Kim T.H., Kim S.I., Akaike T., and Cho C.S. Synergistic effect of poly(ethylenimine) on the transfection efficiency of galactosylated chitosan/DNA complexes. J Control Release 105 (2005) 354-366
36. Sullivan N.J., Sanchez A., Rollin P.E., Yang Z.Y., and Nabel G.J. Development of a preventive vaccine for Ebola virus infection in primates. Nature 408 (2000) 605-609
37. Sullivan N.J., Geisbert T.W., Geisbert J.B., Xu L., Yang Z.Y., Roederer M., et al. Accelerated vaccination for Ebola virus haemorrhagic fever in non-human primates. Nature 424 (2003) 681-684